NBIX

$0.00

(

0.00%

)
Quote details

stock

Neurocrine Biosciences Inc

NASDAQ | NBIX

141.47

USD

$0.00

(

0.00%

)

At Close (As of Oct 22, 2025)

$14.15B

Market Cap

42.2

P/E Ratio

3.38

EPS

$154.61

52 Week High

$84.23

52 Week Low

HEALTHCARE

Sector

NBIX Chart

Recent Chart
Price Action

NBIX Technicals

Tags:

NBIX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.3B
Total Revenue $2.4B
Cost Of Revenue $34M
Costof Goods And Services Sold $34M
Operating Income $571M
Selling General And Administrative $1B
Research And Development $731M
Operating Expenses $1.8B
Investment Income Net -
Net Interest Income $91M
Interest Income $91M
Interest Expense $127M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $27M
Income Before Tax $486M
Income Tax Expense $145M
Interest And Debt Expense -
Net Income From Continuing Operations $341M
Comprehensive Income Net Of Tax -
Ebit $613M
Ebitda $640M
Net Income $341M

Revenue & Profitability

Earnings Performance

NBIX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $3.7B
Total Current Assets $1.7B
Cash And Cash Equivalents At Carrying Value $233M
Cash And Short Term Investments $233M
Inventory $57M
Current Net Receivables $479M
Total Non Current Assets $2B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $37M
Intangible Assets Excluding Goodwill $37M
Goodwill -
Investments -
Long Term Investments $864M
Short Term Investments $843M
Other Current Assets $112M
Other Non Current Assets -
Total Liabilities $1.1B
Total Current Liabilities $508M
Current Accounts Payable $110M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $621M
Capital Lease Obligations $455M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $455M
Other Current Liabilities $398M
Other Non Current Liabilities $5.5M
Total Shareholder Equity $2.6B
Treasury Stock -
Retained Earnings $29M
Common Stock $100K
Common Stock Shares Outstanding $104M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $595M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $27M
Capital Expenditures $38M
Change In Receivables -
Change In Inventory -$19M
Profit Loss -
Cashflow From Investment -$127M
Cashflow From Financing -$487M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$300M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $341M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.3B
Total Revenue $2.4B
Cost Of Revenue $34M
Costof Goods And Services Sold $34M
Operating Income $571M
Selling General And Administrative $1B
Research And Development $731M
Operating Expenses $1.8B
Investment Income Net -
Net Interest Income $91M
Interest Income $91M
Interest Expense $127M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $27M
Income Before Tax $486M
Income Tax Expense $145M
Interest And Debt Expense -
Net Income From Continuing Operations $341M
Comprehensive Income Net Of Tax -
Ebit $613M
Ebitda $640M
Net Income $341M

NBIX News

NBIX Profile

Neurocrine Biosciences Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Neurocrine Biosciences, Inc. (NBIX), based in San Diego, California, is a leading biopharmaceutical company specializing in the development of innovative treatments for neurological, endocrine, and psychiatric disorders. The company boasts a robust pipeline, including advanced therapies targeting Parkinson's disease, epilepsy, and various other serious medical conditions, addressing critical unmet needs in patient care. Neurocrine's commitment to scientific excellence and strategic partnerships positions it for significant growth and continued contributions to the biopharmaceutical landscape, enhancing outcomes for patients worldwide.

YYAI
+133.74%
$0.18
BYND
-1.10%
$3.58
VHAI
0.00%
$0.00
BURU
+24.34%
$0.36
YDKG
+19.92%
$0.06
ADAP
+49.17%
$0.07
F
-1.03%
$12.43
BENF
+205.95%
$1.49
AIRE
+2.00%
$0.74
CGBS
-39.47%
$0.03
NVDA
-0.48%
$180.28
BITF
-12.24%
$3.94
DNUT
+8.62%
$4.03
RGTI
-9.85%
$36.06
PLUG
-8.23%
$3.12
DNN
0.00%
$2.72
T
-1.91%
$25.55
WTO
+10.81%
$0.07
TLRY
-2.02%
$1.45
INTC
-3.14%
$36.92
QBTS
-15.22%
$27.29
RIG
+3.32%
$3.42
TSLA
-0.82%
$438.97
EPWK
+13.34%
$0.08
SOFI
-5.42%
$27.19
BOF
+33.65%
$2.80
AXDX
-61.36%
$0.03
NOK
-0.53%
$5.55
CIFR
-10.87%
$16.11
BBD
0.00%
$3.30
RF
-0.98%
$24.12
RANI
-15.26%
$2.41
GSIT
-16.26%
$10.86
GPUS
+4.79%
$0.38
CAN
-12.56%
$1.70
AMD
-3.27%
$230.23
AREB
+72.00%
$2.15
IXHL
-2.49%
$0.34
AAL
-2.10%
$12.09
BNBX
+40.35%
$4.80
NVTS
-9.48%
$13.60
ETHD
+10.21%
$4.09
ONDS
-6.25%
$6.74
QS
-12.50%
$13.58
PLTR
-3.01%
$176.03
NIO
+0.58%
$6.84
ABEV
-0.90%
$2.20
WBD
+0.98%
$20.53
QUBT
-7.06%
$14.87
HPE
-0.70%
$23.10
VALE
+2.21%
$11.52
ALEC
-49.84%
$1.61
PFE
-0.46%
$24.73
GRAB
+0.35%
$5.62
IONZ
+13.38%
$4.66
APLD
-5.90%
$30.62
ACHR
-4.75%
$11.41
AAPL
-1.64%
$258.45
BTBT
-7.23%
$3.59
RXRX
-5.89%
$5.75
AMZN
-1.83%
$217.95
SOUN
-2.57%
$17.76
JOBY
-3.91%
$15.47
GPRO
+5.00%
$2.31
RR
-10.12%
$5.05
RIVN
-2.12%
$12.92
CJET
+21.50%
$0.09
AVDL
+3.66%
$18.52
SNAP
-0.95%
$7.77
LAES
-11.47%
$5.40
IREN
-6.79%
$55.19
MARA
-4.58%
$19.14
RMBL
+60.50%
$3.21
UUUU
+10.22%
$22.74
IONQ
-6.80%
$55.45
ADD
-25.47%
$0.05
DVLT
-15.41%
$2.14
BMNR
-7.36%
$48.03
BTG
+0.09%
$5.18
CLSK
-10.17%
$16.86
WULF
-5.59%
$12.40
BAC
-0.83%
$51.09
GOOGL
+0.49%
$251.69
SRM
+53.27%
$10.30
AMC
-4.67%
$2.75
FLWS
-11.43%
$4.56
SMR
-9.53%
$34.71
RGTZ
+19.73%
$18.69
SMCI
-4.23%
$52.50
PBR
+1.42%
$11.72
CUTR
-10.19%
$0.09
NDLS
+33.01%
$0.95
WLGS
-5.57%
$0.04
JBLU
-0.85%
$4.62
ETWO
0.00%
$3.30
CLF
-2.95%
$12.99
BULL
-2.78%
$10.83
GGB
-1.18%
$3.33
EOSE
-7.41%
$15.09
TXN
-5.60%
$170.71
YYAI
+133.74%
$0.18
BYND
-1.10%
$3.58
VHAI
0.00%
$0.00
BURU
+24.34%
$0.36
YDKG
+19.92%
$0.06
ADAP
+49.17%
$0.07
F
-1.03%
$12.43
BENF
+205.95%
$1.49
AIRE
+2.00%
$0.74
CGBS
-39.47%
$0.03
NVDA
-0.48%
$180.28
BITF
-12.24%
$3.94
DNUT
+8.62%
$4.03
RGTI
-9.85%
$36.06
PLUG
-8.23%
$3.12
DNN
0.00%
$2.72
T
-1.91%
$25.55
WTO
+10.81%
$0.07
TLRY
-2.02%
$1.45
INTC
-3.14%
$36.92
QBTS
-15.22%
$27.29
RIG
+3.32%
$3.42
TSLA
-0.82%
$438.97
EPWK
+13.34%
$0.08
SOFI
-5.42%
$27.19
BOF
+33.65%
$2.80
AXDX
-61.36%
$0.03
NOK
-0.53%
$5.55
CIFR
-10.87%
$16.11
BBD
0.00%
$3.30
RF
-0.98%
$24.12
RANI
-15.26%
$2.41
GSIT
-16.26%
$10.86
GPUS
+4.79%
$0.38
CAN
-12.56%
$1.70
AMD
-3.27%
$230.23
AREB
+72.00%
$2.15
IXHL
-2.49%
$0.34
AAL
-2.10%
$12.09
BNBX
+40.35%
$4.80
NVTS
-9.48%
$13.60
ETHD
+10.21%
$4.09
ONDS
-6.25%
$6.74
QS
-12.50%
$13.58
PLTR
-3.01%
$176.03
NIO
+0.58%
$6.84
ABEV
-0.90%
$2.20
WBD
+0.98%
$20.53
QUBT
-7.06%
$14.87
HPE
-0.70%
$23.10
VALE
+2.21%
$11.52
ALEC
-49.84%
$1.61
PFE
-0.46%
$24.73
GRAB
+0.35%
$5.62
IONZ
+13.38%
$4.66
APLD
-5.90%
$30.62
ACHR
-4.75%
$11.41
AAPL
-1.64%
$258.45
BTBT
-7.23%
$3.59
RXRX
-5.89%
$5.75
AMZN
-1.83%
$217.95
SOUN
-2.57%
$17.76
JOBY
-3.91%
$15.47
GPRO
+5.00%
$2.31
RR
-10.12%
$5.05
RIVN
-2.12%
$12.92
CJET
+21.50%
$0.09
AVDL
+3.66%
$18.52
SNAP
-0.95%
$7.77
LAES
-11.47%
$5.40
IREN
-6.79%
$55.19
MARA
-4.58%
$19.14
RMBL
+60.50%
$3.21
UUUU
+10.22%
$22.74
IONQ
-6.80%
$55.45
ADD
-25.47%
$0.05
DVLT
-15.41%
$2.14
BMNR
-7.36%
$48.03
BTG
+0.09%
$5.18
CLSK
-10.17%
$16.86
WULF
-5.59%
$12.40
BAC
-0.83%
$51.09
GOOGL
+0.49%
$251.69
SRM
+53.27%
$10.30
AMC
-4.67%
$2.75
FLWS
-11.43%
$4.56
SMR
-9.53%
$34.71
RGTZ
+19.73%
$18.69
SMCI
-4.23%
$52.50
PBR
+1.42%
$11.72
CUTR
-10.19%
$0.09
NDLS
+33.01%
$0.95
WLGS
-5.57%
$0.04
JBLU
-0.85%
$4.62
ETWO
0.00%
$3.30
CLF
-2.95%
$12.99
BULL
-2.78%
$10.83
GGB
-1.18%
$3.33
EOSE
-7.41%
$15.09
TXN
-5.60%
$170.71

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.